Bio-Gene Technology Ltd.ASX: BGT

Bio-Gene 2018 goals & objectives following successful IPO

· Issued by Bio-Gene Technology Ltd.

Filed with ASX · · 3 pages · English

• Identify appropriate potential partners for product evaluation and development. • Demonstrate the activity of our lead molecules Flavocide™ and Qcide™ in an increased number of market segments and target pests via laboratory studies and field trials. • Implement the regulatory required toxicology and environmental safety studies required for product registration filings. • Continue to develop im

Bio-Gene Technology Ltd. on 6ix

Earlier from Bio-Gene Technology

Later from Bio-Gene Technology

All Bio-Gene Technology news releases